Dezheng Huo to Uterine Neoplasms
This is a "connection" page, showing publications Dezheng Huo has written about Uterine Neoplasms.
Connection Strength
0.065
-
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol. 2010 Apr; 117(1):37-40.
Score: 0.065